Dexmedetomidine sublingual film
2019P002353
Phase 2 small_molecule terminated
Quick answer
Dexmedetomidine sublingual film for Delirium is a Phase 2 program (small_molecule) at BioXcel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioXcel Therapeutics
- Indication
- Delirium
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated